arrow
M

Maya Dadiani

Sheba Medical Center
H指数:16
被引数:3,819

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

InSituPREP enables 3D single-cell mapping of interaction-associated gene programs in the breast cancer tumor microenvironment

InSituPREP实现乳腺癌肿瘤微环境中与相互作用相关的基因程序的三维单细胞映射

2026-05-220
PRE
Deep phenotyping of health–disease continuum in the Human Phenotype Project

人类表型项目中健康-疾病连续体的深度表型分析

2025-07-150
PRE
Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

个体乳腺癌患者化疗耐药组图谱绘制揭示了动态转录适应性多样性

2025-04-280
OAAI
Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches
2024-05-020
PRE
ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells

对乳腺癌细胞的ICAM-1可抑制肺转移,但对肿瘤生长和细胞毒性T细胞杀伤是必不可少的

2022-07-1110
OAAI
Evaluating an ex vivo organ culture system for predicting response to neoadjuvant chemotherapy in breast cancer patients
2022-02-150
PRE
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome
2020-06-29188
OA
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis (vol 22, 16, 2020)
2020-03-122
OAAI
The human tumor microbiome is composed of tumor type–specific intracellular bacteria

人类肿瘤微生物组由肿瘤类型特异性细胞内细菌组成

Science
IF45.8
2020-01-010
OAAI
Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers

新辅助阿霉素和环磷酰胺联合紫杉醇治疗BRCA1突变携带者和非携带者的三阴性乳腺癌

2016-04-2539
PREAI